Want to see KRYS full AI Analyst Report?
Krystal Biotech (KRYS) Ownership Overview
10.99% Insiders
30.30% Mutual Funds
33.56% Other Institutional Investors
22.55% ETFs
2.59% Public Companies and Individual Investors
The ownership structure of Krystal Biotech (KRYS) stock is a mix of institutional, retail, and individual investors. Approximately 86.41% of the company’s stock is owned by Institutional Investors, 10.99% is owned by Insiders, and 2.59% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 14, 2026 | xxxxxxxxxxxxx | $8227864 | |
Jun 05, 2026 | xxxxxxxxxxxxx | $7606424 | |
Jun 05, 2026 | xxxxxxxxxxxxx | $7606581 | |
Mar 06, 2026 | xxxxxxxxxxxxx | $6475427 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2026 | xxxxxxxxxxxxx | $258320 | |
Mar 31, 2026 | xxxxxxxxxxxxx | $22271059 | |
Mar 31, 2026 | xxxxxxxxxxxxx | $10365865 | |
Mar 31, 2026 | xxxxxxxxxxxxx | $11977523 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,559,113 | Institution | 8.65% | 859,171,007 | |
| 2,313,169 | Institution | 7.82% | 776,600,228 | |
| 2,064,593 | Institution | 6.98% | 693,145,808 | |
| 1,806,522 | Institution | 6.10% | 606,503,631 | |
| 1,590,253 | Insider | 5.37% | 533,895,640 | |
| 1,518,155 | Insider | 5.13% | 509,690,178 | |
| 1,204,537 | Institution | 4.07% | 404,399,207 | |
| 908,203 | Institution | 3.07% | 304,910,993 | |
| 752,244 | Institution | 2.54% | 252,550,878 | |
| 329,780 | Institution | 1.11% | 110,717,039 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,064,593 | Institution | 6.98% | 693,145,808 | |
| 1,806,522 | Institution | 6.10% | 606,503,631 | |
| 1,204,537 | Institution | 4.07% | 404,399,207 | |
| 752,244 | Institution | 2.54% | 252,550,878 | |
| 329,780 | Institution | 1.11% | 110,717,039 | |
| 273,451 | Institution | 0.92% | 91,805,704 | |
| 267,817 | Institution | 0.90% | 89,914,201 | |
| 260,883 | Institution | 0.88% | 87,586,250 | |
| 194,998 | Institution | 0.66% | 65,466,679 | |
| 178,728 | Institution | 0.60% | 60,004,351 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 906,259 | Institution | 3.06% | 304,258,334 | |
| 892,449 | Institution | 3.02% | 304,432,203 | |
| 668,360 | Institution | 2.26% | 224,388,503 | |
| 642,280 | Institution | 2.17% | 238,716,208 | |
| 372,591 | Institution | 1.26% | 127,098,242 | |
| 323,959 | Institution | 1.09% | 107,641,857 | |
| 301,962 | Institution | 1.02% | 103,005,277 | |
| 237,494 | Institution | 0.80% | 79,733,861 | |
| 193,914 | Institution | 0.66% | 65,102,747 | |
| 190,808 | Institution | 0.64% | 64,059,970 |
FAQ
Who Owns Krystal Biotech (KRYS)?
According to the latest TipRanks data, approximately 33.56% of the company's stock is held by institutional investors, 10.99% is held by insiders, and 2.59% is held by retail investors.
What percentage of Krystal Biotech (KRYS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 33.56% of Krystal Biotech (KRYS) stock is held by institutional investors.
What percentage of Krystal Biotech (KRYS) stock is held by retail investors?
According to the latest TipRanks data, approximately 2.59% of Krystal Biotech (KRYS) stock is held by retail investors.
Who owns the most shares of Krystal Biotech (KRYS)?
Vanguard owns the most shares of Krystal Biotech (KRYS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.